ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 657

Distinct Contributions of C1q and C3 in Preventing Immunogenicity of Apoptotic Cells in Lupus

Clayton Sontheimer1, Yenly Nguyen2, Keith B. Elkon3 and YuFeng Peng3, 1Pediatric Rheumatology, University of Washington, Seattle, WA, 2University of Washington, Seattle, WA, 3Rheumatology, University of Washington, Seattle, WA

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: apoptotic clearance, nephritis and skin, SLE

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Lupus Erythematosus - Animal Models

Session Type: Abstract Submissions (ACR)

            Background/Purpose: Defective clearance of apoptotic cells (AC) and complement deficiency are important contributors to the pathogenesis of systemic lupus. Dead (sunburn) cells and complement activation are also observed in patients with cutaneous lupus. ACs are opsonized by several proteins including C1q, C3 and MFG-E8. MFG-E8 is a soluble milk protein that binds to phosphatidylserine on AC and facilitates their removal through its interaction with avb3 and avb5 integrins on phagocytes. In its absence, AC debris accumulates in germinal centers. In MFG-E8-/- B6 mice, we observed a C1q dependent increase of  C3/IgG deposition on MZ B cell and FDCs, suggesting excessive self antigens can  activate the classical pathway and be presented as antigen/immune complexes to autoreactive B cells in spleen. In this study, we determined how the interaction between AC and complement contribute to autoantibody production, nephritis and photosensitivity in lupus.

            Methods:  We introduced MFG-E8-/-, C1q-/- and C3-/- into SLE 1 congenic mice. We created MFG-E8-/-C1q-/- and MFG-E8-/-C3-/- double knock-out in the SLE1 background. We analyzed the titers of anti-chromatin and anti-dsDNA (n =15-20 in each group) by ELISA and confirmed the results by Crithidia luciliae staining. We examined T and B cell phenotypes by flow cytometry. Kidney damage was evaluated by blood urea nitrogen, immuno-fluorescence and PAS staining. We exposed respective strains to repeated UVB irradiation and followed development of nephritis and skin lesions.

            Results:   In 7 month old female B6.SLE1 mice, 10% of mice developed anti-dsDNA IgG. Neither C1q nor C3 deficiency alone changed the percentages of anti-dsDNA IgG+ mice. MFG-E8-/- SLE1 mice had a significantly higher number of germinal center B cells and 30% of females became anti-dsDNA IgG+. Combining MFG-E8-/- with either C1q-/- or C3-/- significantly accelerated the production of anti-dsDNA IgG and increased the percentage of anti-dsDNA IgG+ mice to 65% and 80%, respectively (Figure). Furthermore, 50% MFG-E8-/-C1q-/- but 0% FG-E8-/-C3-/- SLE1 mice showed early mortality due to spontaneous lupus nephritis. When exposed to UVB irradiation, 90% (8 out 9) MFG-E8-/-C3-/- developed either acute nephritis or persistent skin lesions. On the contrary, none of MFG-E8-/-C1q-/- mice (0 out 15) experienced similar symptoms.

Conclusion: Both C1q and C3 are essential

in reducing the immunogenicity of

apoptotic cells in lupus. The protective mechanisms they provide depend on availability of other opsonins and environmental factors such as sunlight exposure.


Disclosure:

C. Sontheimer,
None;

Y. Nguyen,
None;

K. B. Elkon,
None;

Y. Peng,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/distinct-contributions-of-c1q-and-c3-in-preventing-immunogenicity-of-apoptotic-cells-in-lupus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology